RxDoctor Payments Data

Christopher Vanderzant, DO

Neurological Surgery · San Angelo, TXNPI 1285616391

Payments from drug & device makers

$13,982in general payments, 2019–2025

Across 917 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Biogen$940
  • Novartis$850
  • UCB, Inc.$720
  • Amgen$695
  • plus $7K from 43 others

What the payments were for

  • Speaking & faculty fees$961%
  • Travel & lodging$5354%
  • Food & beverage$13,25295%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,982 in reported general payments places this provider in the 65th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas

Medicare billing

Part B allowed, 2024
$109,646
Medicare patients
67
Services billed
13,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BetaseronInterferon Beta-1b11$105,561
Lacosamide33$2,425
Clobazam29$1,283
Memantine Hcl33$805
Gabapentin15$721
Levetiracetam23$608
Memantine Hcl ErMemantine Hcl14$502
Donepezil Hcl54$438
Carbidopa-LevodopaCarbidopa/Levodopa18$322
Tramadol Hcl30$300

Paid to pharmacies, not to this prescriber.

Other neurological surgery in San Angelo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →